242 related articles for article (PubMed ID: 29195711)
1. Better specification of triggers to reduce the number of drug interaction alerts in primary care.
Heringa M; van der Heide A; Floor-Schreudering A; De Smet PAGM; Bouvy ML
Int J Med Inform; 2018 Jan; 109():96-102. PubMed ID: 29195711
[TBL] [Abstract][Full Text] [Related]
2. Lower alert rates by clustering of related drug interaction alerts.
Heringa M; Siderius H; Floor-Schreudering A; de Smet PA; Bouvy ML
J Am Med Inform Assoc; 2017 Jan; 24(1):54-59. PubMed ID: 27107437
[TBL] [Abstract][Full Text] [Related]
3. Reducing Inappropriate Drug Use in Older Patients by Use of Clinical Decision Support in Community Pharmacy: A Mixed-Methods Evaluation.
Mulder-Wildemors LGM; Heringa M; Floor-Schreudering A; Jansen PAF; Bouvy ML
Drugs Aging; 2020 Feb; 37(2):115-123. PubMed ID: 31782128
[TBL] [Abstract][Full Text] [Related]
4. Reduction of clinical support warnings through recategorization of severity levels.
Parke C; Santiago E; Zussy B; Klipa D
Am J Health Syst Pharm; 2015 Jan; 72(2):144-8. PubMed ID: 25550138
[TBL] [Abstract][Full Text] [Related]
5. Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy.
Heringa M; Floor-Schreudering A; Tromp PC; de Smet PA; Bouvy ML
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):82-9. PubMed ID: 26602064
[TBL] [Abstract][Full Text] [Related]
6. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
Buurma H; De Smet PA; Egberts AC
Drug Saf; 2006; 29(8):723-32. PubMed ID: 16872246
[TBL] [Abstract][Full Text] [Related]
7. Management of drug-interaction alerts in community pharmacies.
Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
[TBL] [Abstract][Full Text] [Related]
8. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study.
Horn J; Ueng S
Ann Pharmacother; 2019 Nov; 53(11):1087-1092. PubMed ID: 31296026
[No Abstract] [Full Text] [Related]
10. Customizing clinical decision support to prevent excessive drug-drug interaction alerts.
Horn JR; Hansten PD; Osborn JD; Wareham P; Somani S
Am J Health Syst Pharm; 2011 Apr; 68(8):662-4. PubMed ID: 21460171
[No Abstract] [Full Text] [Related]
11. Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events.
Skalafouris C; Reny JL; Stirnemann J; Grosgurin O; Eggimann F; Grauser D; Teixeira D; Jermini M; Bruggmann C; Bonnabry P; Guignard B
BMC Med Inform Decis Mak; 2022 May; 22(1):146. PubMed ID: 35642053
[TBL] [Abstract][Full Text] [Related]
12. Ability of machine-learning based clinical decision support system to reduce alert fatigue, wrong-drug errors, and alert users about look alike, sound alike medication.
Chen CY; Chen YL; Scholl J; Yang HC; Li YJ
Comput Methods Programs Biomed; 2024 Jan; 243():107869. PubMed ID: 37924770
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.
Zenziper Y; Kurnik D; Markovits N; Ziv A; Shamiss A; Halkin H; Loebstein R
Isr Med Assoc J; 2014 May; 16(5):289-94. PubMed ID: 24979833
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
[TBL] [Abstract][Full Text] [Related]
15. The role of clinical decision support in pharmacist response to drug-interaction alerts.
Miller L; Steinmetz Pater K; Corman S
Res Social Adm Pharm; 2015; 11(3):480-6. PubMed ID: 25636198
[TBL] [Abstract][Full Text] [Related]
16. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
[TBL] [Abstract][Full Text] [Related]
17. Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.
Weingart SN; Seger AC; Feola N; Heffernan J; Schiff G; Isaac T
Drug Saf; 2011 Jul; 34(7):587-93. PubMed ID: 21663334
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach.
Daniels CC; Burlison JD; Baker DK; Robertson J; Sablauer A; Flynn PM; Campbell PK; Hoffman JM
Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30760508
[TBL] [Abstract][Full Text] [Related]
19. Nature and management of duplicate medication alerts.
Heringa M; Floor A; Meijer WM; De Smet PA; Bouvy ML
J Am Med Inform Assoc; 2015 Jul; 22(4):831-7. PubMed ID: 25862764
[TBL] [Abstract][Full Text] [Related]
20. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
